Evaxion A/S (EVAX) bonds
EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$2.78+0.01 (+0.36%)
Close on Nov 17, 2026Market cap $23.19MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$5.31M
$190.00K due within a year
Net debt
-$8.69M
After $14.00M of cash
Implied interest rate
58.33%
FY2025 interest ÷ average debt
Interest coverage
-2.3×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Notes and loans outstanding
Individual notes, bonds and loans
Evaxion A/S's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
See a number that looks wrong?